Hillman Cancer Center, Lab 1.18
5117 Centre Avenue
Pittsburgh, PA 15213
The University of Pittsburgh Cancer Institute (UPCI) Luminex Core Facility was founded
in 2003 by Dr. Anna Lokshin and is located in the Hillman Cancer Center. With
over 22 years of combined Luminex assay experience, the UPCI Luminex Core Facility
staff is familiar with many Luminex protocols and offers researchers accurate, reliable,
and reproducible processing and analysis services.
Luminex technology is a flexible platform that permits the simultaneous quantitative
analysis of up to 100 different proteins, peptides, DNA molecules and much more
from as little as 50μl of sample in a single microtiter well. Luminex is compatible
with various sample matrices such as serum, cell culture supernatants, plasma, saliva,
spinal fluid, tissue homogenate supernatants, urine, and ascites. Popular
applications for Luminex technology include protein, gene and transcription factor
expression profiling, isotyping, mRNA expression, microRNA expression, and signal
transduction; new applications are added frequently.
The UPCI Luminex Core Facility can process and analyze samples using commercially
available manufactured kits or unique Core-developed kits. The UPCI Luminex
Core Facility can also develop custom analyte Luminex assays using investigator-supplied
antibodies and a protein standard.
For additional information on the services provided and pricing, please contact
412-623-7748 or visit our website at